COVID-19 therapeutics II: Inhaled antimiR against inflammatory lung damage caused by COVID-19 (CoVmiR) - preclinical studies
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 16LW0152K
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$4,162,010.1Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
rnatics GmbHResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified